Ceribell, Inc. (CBLL) stock
Close on Nov 11, 2026Market cap $1.07BP/E –Yield –
Ceribell, Inc. grew revenue 31.7% to $101.96M over the twelve months to Jun 30, 2026. Free cash flow was -$54.72M. At the latest close the market valued the company at $1.07B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.07B
- P/E ratio
- –
- Price to sales
- 10.46
- Price to book
- 8.31
- Dividend yield
- –
- Free cash flow yield
- -5.13%
Fundamentals
- Revenue
- $101.96M
- Net income
- -$66.00M
- EPS, diluted
- -$1.76
- Free cash flow
- -$54.72M
- Book value per share
- $3.37
- Diluted shares
- 38M
Trading
- Next earnings
- Feb 23, 2027 (estimated, after the close)
- Previous close
- $27.48
- Open
- $27.79
- Day's range
- $27.58 – $28.27
- Volume
- 232,753
- Average volume (20 days)
- 612,445
- Index membership
- Russell 2000 (since Dec 2024), Russell 3000 (since Feb 2025)
- Beta (5 years)
- 0.84
- 52-week range
- $11.75 – $28.89
- RSI (14 days)
- 57.3
- Volatility (1 year)
- 51.1%
- Relative volume
- 0.54×
- WACC
- 9.0%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | CBLL | S&P 500 | Difference | CBLL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +17.6% | -2.4% | +20.1 pts | ||
| 3 months | +30.5% | -1.2% | +31.6 pts | ||
| Year to date | +26.8% | +12.3% | +14.5 pts | ||
| 1 year | +122.0% | +12.4% | +109.6 pts |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Ceribell filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- News
- News
About Ceribell
Electromedical & Electrotherapeutic Apparatus
CeriBell, Inc. is a medical technology company that provides point-of-care electroencephalography (EEG) diagnostic and monitoring solutions for acute care settings. Its primary offering is the Ceribell System, which pairs artificial intelligence algorithms with portable hardware, including disposable headbands, headcaps, and a pocket-sized recorder, alongside a web-based portal for remote data access. Through its Clarity system and monitoring tools, the company serves hospitals, clinicians, and neurologists managing critically ill patients experiencing or at risk of seizures and status epilepticus.
Company profile, executives and historyCeribell stock: common questions
What is Ceribell's stock price?
CBLL closed at $27.80 on Nov 11, 2026, up 1.16% on the day. Over the past 52 weeks it traded between $11.75 and $28.89.
What is Ceribell's market cap?
Ceribell was worth $1.07B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is CBLL's P/E ratio?
Ceribell lost money over the twelve months to Jun 30, 2026 (diluted EPS -$1.76), so it has no meaningful P/E ratio.
How much revenue does Ceribell make?
Ceribell reported revenue of $101.96M for the twelve months to Jun 30, 2026, up 31.7% from a year earlier.
Does Ceribell pay a dividend?
No. Ceribell has not paid a cash dividend over the last twelve months.
When does Ceribell report earnings next?
Ceribell is expected to report Q4 FY2026 results on Feb 23, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has CBLL stock performed over the past year?
Including dividends, CBLL returned +122.0% over the past year, against +12.4% for the S&P 500.
How many CBLL shares are sold short?
2M shares were sold short at the latest FINRA report, 6.96% of the float, or 3.5 days of average trading volume.
Who are Ceribell's competitors?
Companies most similar to Ceribell by business, industry and size include OM, HYPR, NPCE, ELMD, VASO.
See a number that looks wrong?